The study collected blood samples from 91 patients with mRCC and 32 healthy individuals, and associated serum CA-IX levels with the occurrence of tumor progression (stage, tumor grade, tumor size, recurrence, and metastasis), suggesting that CA-IX may be a valuable diagnostic and prognostic tool in RCC [164]. The gene discussed is CA9; the disease is renal cell carcinoma.